Clinical Dementia Rating

The Clinical Dementia Rating (CDR) is a widely used tool to assess the severity of dementia, including Alzheimer's disease. It evaluates cognitive and functional impairments across six domains: memory, orientation, judgment and problem-solving, community affairs, home and hobbies, and personal care. The CDR scale categorizes individuals into five stages: 0 (no impairment), 0.5 (questionable impairment), 1 (mild), 2 (moderate), and 3 (severe dementia). This structured approach helps clinicians and researchers standardize the assessment of dementia progression and tailor appropriate care plans. By systematically evaluating both cognitive decline and functional abilities, the CDR provides valuable insights into disease severity and helps track changes over time, crucial for understanding the impact of Alzheimer's and other forms of dementia on individuals and guiding clinical interventions.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China
Tags

Submit your abstract Today

Whatsapp